Treatment of metastatic colorectal cancer: focus on panitumumab

Targeted agents are an important therapeutic option in the treatment of metastatic colorectal cancer (mCRC). Panitumumab is a recombinant, fully humanized, immunoglobulin G2 monoclonal antibody that targets the epidermal growth factor receptor (EGFR) with efficacy in mCRC as monotherapy and in combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, Rebecca Y, Wong, Rachel, Hawkes, Eliza A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484697/
https://www.ncbi.nlm.nih.gov/pubmed/26150735
http://dx.doi.org/10.2147/CMAR.S71821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484697/
https://www.ncbi.nlm.nih.gov/pubmed/26150735
http://dx.doi.org/10.2147/CMAR.S71821

Ejemplares similares